Assignee
PHARMALEADS
FR8 patents
Top patents by PatentIndex Score
US7875436B2Jan 25, 2011
Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof
PHARMALEADS8 citations82
US9388129B2Jul 12, 2016
Mixed inhibitors of aminopeptidase N and neprilysin
PHARMALEADS2 citations60
US11648231B2May 16, 2023
Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain
PHARMALEADS1 citations56
US11090317B2Aug 17, 2021
Aminophosphinic derivatives for preventing and treating eye inflammation
PHARMALEADS1 citations50
US10131681B2Nov 20, 2018
Aminophosphinic derivatives that can be used in the treatment of pain
PHARMALEADS1 citations49
US12391710B2Aug 19, 2025
Method for the industrial preparation of the disodium salt of ((2S)-3-([1,1′-biphenyl]-4-yl-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-l-alanine
PHARMALEADS0 citations39
US10399936B2Sep 3, 2019
Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt
PHARMALEADS0 citations32
US10688113B2Jun 23, 2020
Methods of treating eye pain with aminophosphinic derivatives
PHARMALEADS0 citations30